Revance Therapeutic (RVNC) PT Raised to $39 at Piper Sandler

February 10, 2021 9:12 AM EST
Get Alerts RVNC Hot Sheet
Price: $26.82 -4.76%

Rating Summary:
    14 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE
Piper Sandler analyst David Amsellem raised the price target on Revance Therapeutic (NASDAQ: RVNC) to $39.00 (from $36.00) while maintaining a Overweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change